FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Deutsche Boerse AG 15:50:27 2024-06-21 EDT | ||
| 47.9 EUR | +1.96% |
|
| Current month | -3.62% | ||
| 1 month | -9.76% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 47.9 | +1.96% |
| 24-06-20 | 46.98 | +3.46% |
| 24-06-19 | 45.41 | -1.48% |
| 24-06-18 | 46.09 | +0.04% |
| 24-06-17 | 46.07 | -2.56% |
Delayed Quote Deutsche Boerse AG
Last update June 21, 2024 at 03:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PG3QDG |
| ISIN | DE000PG3QDG5 |
| Date issued | 2023-11-07 |
| Strike | 138.2 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 50 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 56.43 € |
|---|---|
| Lowest since issue | 33.78 € |
| Spread | 1.03 € |
| Spread % | 2.11% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
139
USD
Average target price
147
USD
Spread / Average Target
+5.79%
- Stock Market
- Certificates
- Certificat
